Automated and closed cell therapy processing systems are specialized technologies used in the field of regenerative medicine and cell therapy. These systems refer to the use of automated technology and equipment to perform various steps involved in the manufacturing and processing of cell-based therapies. This includes processes such as cell isolation, expansion, culture, harvesting, and quality control. Automation aims to reduce variability, improve reproducibility, and enhance the efficiency of cell therapy production. By automating these processes, it becomes possible to achieve higher throughput, maintain sterility, and ensure consistency in the final product. Closed systems in cell therapy processing refer to the use of fully enclosed environments and devices that minimize the exposure of cells to the external environment throughout the manufacturing process. Closed systems are critical for maintaining the safety and quality of cell therapies by reducing the risk of microbial contamination and protecting the cells from exposure to harmful agents.
The global Automated And Closed Cell Therapy Processing Systems market was valued at US$ 936 million in 2023 and is anticipated to reach US$ 3571 million by 2030, witnessing a CAGR of 20.3% during the forecast period 2024-2030.
North America is the largest Automated and Closed Cell Therapy Processing Systems market, which has a share about 41%, followed by Asia-Pacific and Europe with a market share of 34% and 24%, respectively. In terms of product type, Non-Stem Cell Therapy is the largest segment, occupied for a share of 90%. And in terms of application, Industry is the largest segment, which has a share about 66%.
This report aims to provide a comprehensive presentation of the global market for Automated And Closed Cell Therapy Processing Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Automated And Closed Cell Therapy Processing Systems.
The Automated And Closed Cell Therapy Processing Systems market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Automated And Closed Cell Therapy Processing Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Automated And Closed Cell Therapy Processing Systems companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Cytiva
Miltenyi Biotec
Thermo Fisher Scientific
Terumo
Merck
Fresenius Kabi
Sartorius
Lonza
Boyalife (ThermoGenesis)
EurekaBio
Segment by Type
Stem Cell Therapy
Non-Stem Cell Therapy
Segment by Application
Academia
Industry
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Automated And Closed Cell Therapy Processing Systems company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Automated And Closed Cell Therapy Processing Systems 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Stem Cell Therapy
1.2.3 Non-Stem Cell Therapy
1.3 麻豆原创 by Application
1.3.1 Global Automated And Closed Cell Therapy Processing Systems 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Academia
1.3.3 Industry
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Automated And Closed Cell Therapy Processing Systems 麻豆原创 Perspective (2019-2030)
2.2 Global Automated And Closed Cell Therapy Processing Systems Growth Trends by Region
2.2.1 Global Automated And Closed Cell Therapy Processing Systems 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Automated And Closed Cell Therapy Processing Systems Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Automated And Closed Cell Therapy Processing Systems Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Automated And Closed Cell Therapy Processing Systems 麻豆原创 Dynamics
2.3.1 Automated And Closed Cell Therapy Processing Systems Industry Trends
2.3.2 Automated And Closed Cell Therapy Processing Systems 麻豆原创 Drivers
2.3.3 Automated And Closed Cell Therapy Processing Systems 麻豆原创 Challenges
2.3.4 Automated And Closed Cell Therapy Processing Systems 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Automated And Closed Cell Therapy Processing Systems Players by Revenue
3.1.1 Global Top Automated And Closed Cell Therapy Processing Systems Players by Revenue (2019-2024)
3.1.2 Global Automated And Closed Cell Therapy Processing Systems Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Automated And Closed Cell Therapy Processing Systems 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Automated And Closed Cell Therapy Processing Systems Revenue
3.4 Global Automated And Closed Cell Therapy Processing Systems 麻豆原创 Concentration Ratio
3.4.1 Global Automated And Closed Cell Therapy Processing Systems 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Automated And Closed Cell Therapy Processing Systems Revenue in 2023
3.5 Global Key Players of Automated And Closed Cell Therapy Processing Systems Head office and Area Served
3.6 Global Key Players of Automated And Closed Cell Therapy Processing Systems, Product and Application
3.7 Global Key Players of Automated And Closed Cell Therapy Processing Systems, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Automated And Closed Cell Therapy Processing Systems Breakdown Data by Type
4.1 Global Automated And Closed Cell Therapy Processing Systems Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Automated And Closed Cell Therapy Processing Systems Forecasted 麻豆原创 Size by Type (2025-2030)
5 Automated And Closed Cell Therapy Processing Systems Breakdown Data by Application
5.1 Global Automated And Closed Cell Therapy Processing Systems Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Automated And Closed Cell Therapy Processing Systems Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Automated And Closed Cell Therapy Processing Systems 麻豆原创 Size (2019-2030)
6.2 North America Automated And Closed Cell Therapy Processing Systems 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Automated And Closed Cell Therapy Processing Systems 麻豆原创 Size by Country (2019-2024)
6.4 North America Automated And Closed Cell Therapy Processing Systems 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Automated And Closed Cell Therapy Processing Systems 麻豆原创 Size (2019-2030)
7.2 Europe Automated And Closed Cell Therapy Processing Systems 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Automated And Closed Cell Therapy Processing Systems 麻豆原创 Size by Country (2019-2024)
7.4 Europe Automated And Closed Cell Therapy Processing Systems 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Automated And Closed Cell Therapy Processing Systems 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Automated And Closed Cell Therapy Processing Systems 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Automated And Closed Cell Therapy Processing Systems 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Automated And Closed Cell Therapy Processing Systems 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Automated And Closed Cell Therapy Processing Systems 麻豆原创 Size (2019-2030)
9.2 Latin America Automated And Closed Cell Therapy Processing Systems 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Automated And Closed Cell Therapy Processing Systems 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Automated And Closed Cell Therapy Processing Systems 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Automated And Closed Cell Therapy Processing Systems 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Automated And Closed Cell Therapy Processing Systems 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Automated And Closed Cell Therapy Processing Systems 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Automated And Closed Cell Therapy Processing Systems 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cytiva
11.1.1 Cytiva Company Details
11.1.2 Cytiva Business Overview
11.1.3 Cytiva Automated And Closed Cell Therapy Processing Systems Introduction
11.1.4 Cytiva Revenue in Automated And Closed Cell Therapy Processing Systems Business (2019-2024)
11.1.5 Cytiva Recent Development
11.2 Miltenyi Biotec
11.2.1 Miltenyi Biotec Company Details
11.2.2 Miltenyi Biotec Business Overview
11.2.3 Miltenyi Biotec Automated And Closed Cell Therapy Processing Systems Introduction
11.2.4 Miltenyi Biotec Revenue in Automated And Closed Cell Therapy Processing Systems Business (2019-2024)
11.2.5 Miltenyi Biotec Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Automated And Closed Cell Therapy Processing Systems Introduction
11.3.4 Thermo Fisher Scientific Revenue in Automated And Closed Cell Therapy Processing Systems Business (2019-2024)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Terumo
11.4.1 Terumo Company Details
11.4.2 Terumo Business Overview
11.4.3 Terumo Automated And Closed Cell Therapy Processing Systems Introduction
11.4.4 Terumo Revenue in Automated And Closed Cell Therapy Processing Systems Business (2019-2024)
11.4.5 Terumo Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Automated And Closed Cell Therapy Processing Systems Introduction
11.5.4 Merck Revenue in Automated And Closed Cell Therapy Processing Systems Business (2019-2024)
11.5.5 Merck Recent Development
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Details
11.6.2 Fresenius Kabi Business Overview
11.6.3 Fresenius Kabi Automated And Closed Cell Therapy Processing Systems Introduction
11.6.4 Fresenius Kabi Revenue in Automated And Closed Cell Therapy Processing Systems Business (2019-2024)
11.6.5 Fresenius Kabi Recent Development
11.7 Sartorius
11.7.1 Sartorius Company Details
11.7.2 Sartorius Business Overview
11.7.3 Sartorius Automated And Closed Cell Therapy Processing Systems Introduction
11.7.4 Sartorius Revenue in Automated And Closed Cell Therapy Processing Systems Business (2019-2024)
11.7.5 Sartorius Recent Development
11.8 Lonza
11.8.1 Lonza Company Details
11.8.2 Lonza Business Overview
11.8.3 Lonza Automated And Closed Cell Therapy Processing Systems Introduction
11.8.4 Lonza Revenue in Automated And Closed Cell Therapy Processing Systems Business (2019-2024)
11.8.5 Lonza Recent Development
11.9 Boyalife (ThermoGenesis)
11.9.1 Boyalife (ThermoGenesis) Company Details
11.9.2 Boyalife (ThermoGenesis) Business Overview
11.9.3 Boyalife (ThermoGenesis) Automated And Closed Cell Therapy Processing Systems Introduction
11.9.4 Boyalife (ThermoGenesis) Revenue in Automated And Closed Cell Therapy Processing Systems Business (2019-2024)
11.9.5 Boyalife (ThermoGenesis) Recent Development
11.10 EurekaBio
11.10.1 EurekaBio Company Details
11.10.2 EurekaBio Business Overview
11.10.3 EurekaBio Automated And Closed Cell Therapy Processing Systems Introduction
11.10.4 EurekaBio Revenue in Automated And Closed Cell Therapy Processing Systems Business (2019-2024)
11.10.5 EurekaBio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Cytiva
Miltenyi Biotec
Thermo Fisher Scientific
Terumo
Merck
Fresenius Kabi
Sartorius
Lonza
Boyalife (ThermoGenesis)
EurekaBio
听
听
*If Applicable.
